Exicure, Inc. does not have significant operations. Previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California. Show more

Location: 400 Seaport Court, Redwood City, CA, 94063, United States | Website: https://www.exicuretx.com | Industry: Biotechnology | Sector: Healthcare

Market Cap

35.57M

52 Wk Range

$3.10 - $15.91

Previous Close

$5.42

Open

$5.41

Volume

27,311

Day Range

$5.31 - $5.62

Enterprise Value

30.47M

Cash

4.438M

Avg Qtr Burn

-2.063M

Insider Ownership

62.59%

Institutional Own.

6.15%

Qtr Updated

09/30/25

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Burixafor Details Multiple myeloma	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.